The Gross Margin of North China Pharmaceutical Co Ltd (600812.SS) is 31.84%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 31.84% |
2022-12-31 | 32.79% |
2021-12-31 | 35.63% |
2020-12-31 | 36.28% |
2019-12-31 | 41.31% |
2018-12-31 | 41.57% |
2017-12-31 | 31.22% |
2016-12-31 | 19.07% |
2015-12-31 | 17.90% |
2014-12-31 | 15.98% |